Yep I agree, I want a free look at 2571. Not being an insider, or a scientist, my take is this. JP is in the best spot to predict the efficacy of 2591 at this point in time. If he has publicly stated he would prefer not to entertain T/O offers prior to the P2 results being released- in my mind that says he's pretty confident. From a logical point of view, if he was NOT confident about the trials to date, why wouldn't he/management at least entertain the idea of a T/O now? It would be a chance to take a premium now while the getting is good. Logic tells me he wants the 2591 P2 data out there before entertaining T/O offers because he believes the data will be positive, and a T/O before then would sell NEU short. I'm backing the team that got us here- plenty more to come. My opinion only, obviously- and you know what they say about opinions. GLTAH.
What will Neu with surplus funds ??, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |